Cancer Based Genetic Testing Market is Poised to Cross US$ 3 Billion by 2022

2026-08-10 06:46:56 Health and Fitness

863

According to a new research report by RNCOS entitled, ?Global Genetic Testing Market Outlook 2022?, Cancer research and genomics have shown considerable advancements in last two decades resulting into proliferation of knowledge of cancer. This has led to the development of novel therapeutic approaches for cancer which is expected to fuel further growth in this segment. Till date, there is no effective treatment for this deadly disease, which has lead to rise in number of researches focusing on finding various new and advanced approaches for the treatment of this disease.

Cancer is estimated to account for the highest share of above 45% in the genetic testing market in 2016. The genetic testing market for cancer is estimated at US$ 1.4 Billion in 2015. Owing to the rising incidence of cancer cases, cancer genetic testing is expected to present high growth, and would dominate the genetic testing market by 2022. Presently, cancer accounts for almost half of the projects which are currently underway.

Currently tests are available for various gene faults that increase the risk of breast cancer, bowel cancer, ovarian cancer, womb cancer and prostate cancer. Tests are also available for rare gene faults which might increase the risk of kidney cancer, melanoma skin cancer, pancreatic cancer, thyroid cancer and retinoblastoma.

Research Analysis and Highlights

The report provides an in-depth research and rational analysis of the current status and future prospect of the Global Genetic Testing Market Outlook 2022. The study presents a transparent picture about the current and future market outlook, in terms of the disease profile, applications and geography. The report also provides a comprehensive insight about the market dynamics including the drivers, challenges, opportunities, and upcoming trends that would influence the market. The report also discusses the recent mergers & acquisitions and the genetic testing regulations scenario.

The report also covers detailed information about key players in the global genetic testing market, to enable the clients to understand the market structure and its growth during the forecasted period. In brief, the report, ?Global Genetic Testing Market Outlook 2022?, covers all the necessary aspects of the global genetic testing market, providing an in-depth research and prudent analysis of the key segments.

Some of the key highlights of the report include the following:

? Growth drivers such as rising prevalence of chronic diseases, increasing government initiatives, rising investments and incessant launch of new genetic tests are fueling growth in this sector.
? Holistic view of the genetic testing market, segmentation in terms of the disease profile, application, and the regional prevalence.
? Diagnostic testing and Newborn screening-the major application areas of genetic testing industry.
? SWOT analysis and the product portfolio of the leading players in the genetic testing market.

For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM840.htm

Check Related REPORTS on: http://www.rncos.com/Healthcare_Industry.htm

ABOUT RNCOS

RNCOS is a leading industry research and consultancy firm incorporated in 2002. As a pioneer in syndicate market research, our vision is to be a global leader in the industry research space by providing research reports and actionable insights to companies across a range of industries such as Healthcare, IT and Telecom and Retail etc. We offer comprehensive industry research studies, bespoke research and consultancy services to Fortune 1000, Trade associations, and Government agencies worldwide.